Skip to main content
OpenTrials

Clinical trial condition

Deglutition Disorders

Explore clinical trials studying Deglutition Disorders. Study availability and eligibility vary by location and protocol.

976 public trials 124 recruiting studies
Refine in advanced search Browse all conditions

Deglutition Disorders trial results

Completed

ASTERIX: Low Dose ASA and Nexium

NCT00251966

Conditions
Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +3 more
Locations
  • Research Site Bondi Junction, New South Wales, Australia
  • Research Site Bracken Ridge, Queensland, Australia
  • Research Site Carina Heights, Queensland, Australia
  • Research Site Adelaide, South Australia, Australia
View all 94 locations
View Trial Details
Completed

Canadian, Multi-Centre Study of Symptom Burden and Clinical Management in Subjects With GERD

NCT00634023

Conditions
Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +4 more
Locations
  • Research Site Edmonton, Alberta, Canada
  • Research Site Spruce Grove, Alberta, Canada
  • Research Site North Vancouver, British Columbia, Canada
  • Research Site Windsor, Nova Scotia, Canada
View all 15 locations
View Trial Details
Completed

PPI Sequencing Study

NCT00384592

Conditions
Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +8 more
Locations
  • Research Site Allerton, United Kingdom
  • Research Site Ashford, United Kingdom
  • Research Site Atherstone, United Kingdom
  • Research Site Ayrshire, United Kingdom
View all 14 locations
View Trial Details
Completed

Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERD

NCT00410592

Conditions
Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +8 more
Locations
  • Research Site Anaheim, California, United States
  • Research Site Orange, California, United States
  • Research Site San Diego, California, United States
  • Research Site Miami, Florida, United States
View Trial Details
Completed

An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD)

NCT00242736

Conditions
Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +4 more
Locations
  • Research Site Alabaster, Alabama, United States
  • Research Site Mobile, Alabama, United States
  • Research Site Tucson, Arizona, United States
  • Research Site North Little Rock, Arkansas, United States
View all 25 locations
View Trial Details

Related conditions